Codexis rises after Q4 beat, strong outlook
Source: SeekingAlpha
2026-03-12 07:39:54 ET
More on Codexis
- Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
- Codexis outlines $72M–$76M 2026 revenue target as ECO Synthesis gains momentum and CDMO partnerships expand
- Seeking Alpha’s Quant Rating on Codexis
- Historical earnings data for Codexis
- Financial information for Codexis
Read the full article on Seeking Alpha
For further details see:
Codexis rises after Q4 beat, strong outlook
Merck & Company Inc.
NASDAQ: MRK
MRK Trading
1.11% G/L:
$116.48 Last:
2,106,719 Volume:
$116.92 Open:
MRK Latest News
March 05, 2026 10:20:00 am
Forget ImmunityBio: This Big?Cap Pharma Is the Safer Play on Next?Gen Cancer Therapies
March 03, 2026 09:00:00 am
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
MRK Stock Data
$291,612,827,755
2,457,202,311
0.02%
2165
N/A
Pharmaceuticals
Healthcare
US
Rahway
